BARCLAYS PLC - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 70 filers reported holding AC IMMUNE SA in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of AC IMMUNE SA
ValueSharesWeighting
Q3 2021$48,000
+4700.0%
7,068
+5889.8%
0.00%
Q2 2021$1,000
-66.7%
118
-69.9%
0.00%
Q1 2021$3,000
+200.0%
392
+269.8%
0.00%
Q4 2020$1,0000.0%1060.0%0.00%
Q3 2020$1,0000.0%1060.0%0.00%
Q2 2020$1,0000.0%106
-20.9%
0.00%
Q4 2019$1,000
-50.0%
134
-72.3%
0.00%
Q3 2019$2,000
-33.3%
4840.0%0.00%
Q2 2019$3,000
-95.1%
484
-92.4%
0.00%
Q4 2018$61,000
+916.7%
6,378
+726.2%
0.00%
Q3 2018$6,000
-89.5%
772
-86.0%
0.00%
Q1 2018$57,000
-56.5%
5,500
-46.1%
0.00%
Q4 2017$131,00010,2000.00%
Other shareholders
AC IMMUNE SA shareholders Q3 2021
NameSharesValueWeighting ↓
Duquesne Family Office 1,500,000$24,705,0002.18%
Monashee Investment Management LLC 275,000$4,529,0001.59%
SPHERA FUNDS MANAGEMENT LTD. 79,800$1,314,0000.21%
Hillhouse Capital Management 550,000$9,059,0000.18%
Temasek Holdings (Private) Ltd 1,337,500$22,029,0000.18%
PointState Capital LP 425,000$7,000,0000.07%
Artal Group S.A. 150,000$2,471,0000.05%
HIGHLAND CAPITAL MANAGEMENT LP 87,900$1,448,0000.04%
Schonfeld Strategic Advisors LLC 14,779$243,0000.04%
Point72 Hong Kong Ltd 4,000$66,0000.04%
View complete list of AC IMMUNE SA shareholders